Mounjaro is Eli Lilly's brand of tirzepatide for type 2 diabetes. The first dual GIP/GLP-1 receptor agonist. Weekly subcutaneous injection. Most commercial insurance covers for T2D.
At a glance
- Generic name: tirzepatide
- Manufacturer: Eli Lilly
- List price (cash, no coverage): ~$1,069/mo
- Cash-pay program: Lilly savings cards for commercial
FDA-approved indications
- Type 2 diabetes (2022)
Standard dosing
- Start: 2.5 mg/wk × 4 wk
- Titration: 5 → 7.5 → 10 → 12.5 → 15 mg
- Maintenance: 5–15 mg weekly